Languages

Gilteritinib

Drug
Language:
Pronunciation
Gilteritinib
Gilteritinib
SpellingGilteritinib
Pronunciation[Gilteritinib]
Definition
Gilteritinib is a cancer drug. It acts as an inhibitor of AXL receptor tyrosine kinase. It was developed by Astellas Pharma. In April 2018, Astellas filed a new drug application with the Food and Drug Administration for gilteritinib for the treatment of adult patients with FLT3 mutation–positive relapsed or refractory acute myeloid leukemia.
Pronunciation of your name
Record the pronunciation of your name.